Clinical Research Trials Archive – Closed Trials

This is our archive of closed clinical trials, which means that they are no longer accepting new participants or have been concluded. Once a research facility has chosen to close the study, it is sorted into the GPS archive by indication. If you are interested in enrolling in a clinical trial, then please browse our list of active clinical studies.

Zip code

Condition


Search Radius:25 Miles
  • 5
  • 10
  • 15
  • 20
  • 25
  • 30
  • 40
  • 50
  • 100
  • 500
  • All

We've found
4,483
archived clinical trials in
Influenza

Study of Maternal Hepatitis C Infection and Influenza Vaccination in Pregnancy
Analysis of the Maternal-fetal Interface During Maternal Hepatitis C Virus Infection and Influenza Virus Vaccination
Status: Archived
San Francisco General Hospital
mi
from
San Francisco, CA
Study of Maternal Hepatitis C Infection and Influenza Vaccination in Pregnancy
Analysis of the Maternal-fetal Interface During Maternal Hepatitis C Virus Infection and Influenza Virus Vaccination
Status: Archived
Updated: 1/1/1970
San Francisco General Hospital
mi
from
San Francisco, CA
Study to Evaluate Impact of School-based Influenza Vaccination on School Populations
Prospective Study of School-based Influenza Vaccination's Impact on School Populations
Status: Archived
Childrens Hospital Los Angeles
mi
from
Los Angeles, CA
Study to Evaluate Impact of School-based Influenza Vaccination on School Populations
Prospective Study of School-based Influenza Vaccination's Impact on School Populations
Status: Archived
Updated: 1/1/1970
Childrens Hospital Los Angeles
mi
from
Los Angeles, CA
Study to Evaluate Impact of School-based Influenza Vaccination on School Populations
Prospective Study of School-based Influenza Vaccination's Impact on School Populations
Status: Archived
Los Angeles County Department of Public Health
mi
from
Los Angeles, CA
Study to Evaluate Impact of School-based Influenza Vaccination on School Populations
Prospective Study of School-based Influenza Vaccination's Impact on School Populations
Status: Archived
Updated: 1/1/1970
Los Angeles County Department of Public Health
mi
from
Los Angeles, CA
Group Study of the Safety of and Immune Response to a Single Dose of Bird Flu Vaccine (H7N3) in Healthy Adults
Phase 1 Inpatient Study of the Safety and Immunogenicity of One Dose of Live Influenza A Vaccine H7N3 (6-2) AA ca Recombinant (A/Chicken/British Columbia/CN-6/2004 x A/Ann Arbor/6/60 ca), a Live Attenuated Virus Vaccine Candidate for Prevention of Avian Influenza H7N3 Infection in the Event of a Pandemic
Status: Archived
University of Rochester Vaccine Evaluation Isolation Unit, St. Mary's Hospital
mi
from
Rochester, NY
Group Study of the Safety of and Immune Response to a Single Dose of Bird Flu Vaccine (H7N3) in Healthy Adults
Phase 1 Inpatient Study of the Safety and Immunogenicity of One Dose of Live Influenza A Vaccine H7N3 (6-2) AA ca Recombinant (A/Chicken/British Columbia/CN-6/2004 x A/Ann Arbor/6/60 ca), a Live Attenuated Virus Vaccine Candidate for Prevention of Avian Influenza H7N3 Infection in the Event of a Pandemic
Status: Archived
Updated: 1/1/1970
University of Rochester Vaccine Evaluation Isolation Unit, St. Mary's Hospital
mi
from
Rochester, NY
H5N1 Mix and Match With AS03
A Randomized, Double-Blinded, Controlled, Phase I Study in Healthy Adults to Assess the Safety, Reactogenicity, and Immunogenicity of Intramuscular Subvirion Inactivated Monovalent Influenza A/H5N1 Virus Vaccine Administered at Different Dose Levels Given With and Without AS03 Adjuvant
Status: Archived
University of Maryland, Baltimore
mi
from
Baltimore, MD
H5N1 Mix and Match With AS03
A Randomized, Double-Blinded, Controlled, Phase I Study in Healthy Adults to Assess the Safety, Reactogenicity, and Immunogenicity of Intramuscular Subvirion Inactivated Monovalent Influenza A/H5N1 Virus Vaccine Administered at Different Dose Levels Given With and Without AS03 Adjuvant
Status: Archived
Updated: 1/1/1970
University of Maryland, Baltimore
mi
from
Baltimore, MD
H5N1 Mix and Match With AS03
A Randomized, Double-Blinded, Controlled, Phase I Study in Healthy Adults to Assess the Safety, Reactogenicity, and Immunogenicity of Intramuscular Subvirion Inactivated Monovalent Influenza A/H5N1 Virus Vaccine Administered at Different Dose Levels Given With and Without AS03 Adjuvant
Status: Archived
Vanderbilt University Medical Center
mi
from
Nashville, TN
H5N1 Mix and Match With AS03
A Randomized, Double-Blinded, Controlled, Phase I Study in Healthy Adults to Assess the Safety, Reactogenicity, and Immunogenicity of Intramuscular Subvirion Inactivated Monovalent Influenza A/H5N1 Virus Vaccine Administered at Different Dose Levels Given With and Without AS03 Adjuvant
Status: Archived
Updated: 1/1/1970
Vanderbilt University Medical Center
mi
from
Nashville, TN
H5N1 Mix and Match With AS03
A Randomized, Double-Blinded, Controlled, Phase I Study in Healthy Adults to Assess the Safety, Reactogenicity, and Immunogenicity of Intramuscular Subvirion Inactivated Monovalent Influenza A/H5N1 Virus Vaccine Administered at Different Dose Levels Given With and Without AS03 Adjuvant
Status: Archived
Baylor School of Medicine
mi
from
Houston, TX
H5N1 Mix and Match With AS03
A Randomized, Double-Blinded, Controlled, Phase I Study in Healthy Adults to Assess the Safety, Reactogenicity, and Immunogenicity of Intramuscular Subvirion Inactivated Monovalent Influenza A/H5N1 Virus Vaccine Administered at Different Dose Levels Given With and Without AS03 Adjuvant
Status: Archived
Updated: 1/1/1970
Baylor School of Medicine
mi
from
Houston, TX
H5N1 Mix and Match With AS03
A Randomized, Double-Blinded, Controlled, Phase I Study in Healthy Adults to Assess the Safety, Reactogenicity, and Immunogenicity of Intramuscular Subvirion Inactivated Monovalent Influenza A/H5N1 Virus Vaccine Administered at Different Dose Levels Given With and Without AS03 Adjuvant
Status: Archived
Group Health Cooperative Center for Health Studies
mi
from
Seattle, WA
H5N1 Mix and Match With AS03
A Randomized, Double-Blinded, Controlled, Phase I Study in Healthy Adults to Assess the Safety, Reactogenicity, and Immunogenicity of Intramuscular Subvirion Inactivated Monovalent Influenza A/H5N1 Virus Vaccine Administered at Different Dose Levels Given With and Without AS03 Adjuvant
Status: Archived
Updated: 1/1/1970
Group Health Cooperative Center for Health Studies
mi
from
Seattle, WA
H5N1 Mix and Match With MF59
A Randomized, Double-Blinded, Controlled, Phase I Study in Healthy Adults to Assess the Safety, Reactogenicity, and Immunogenicity of Intramuscular Subvirion Inactivated Monovalent Influenza A/H5N1 Virus Vaccine Administered at Different Dose Levels Given With and Without MF59 Adjuvant
Status: Archived
Children's Healthcare of Atlanta at Egleston - Pediatric Cardiac Intensive Care Unit
mi
from
Atlanta, GA
H5N1 Mix and Match With MF59
A Randomized, Double-Blinded, Controlled, Phase I Study in Healthy Adults to Assess the Safety, Reactogenicity, and Immunogenicity of Intramuscular Subvirion Inactivated Monovalent Influenza A/H5N1 Virus Vaccine Administered at Different Dose Levels Given With and Without MF59 Adjuvant
Status: Archived
Updated: 1/1/1970
Children's Healthcare of Atlanta at Egleston - Pediatric Cardiac Intensive Care Unit
mi
from
Atlanta, GA
H5N1 Mix and Match With MF59
A Randomized, Double-Blinded, Controlled, Phase I Study in Healthy Adults to Assess the Safety, Reactogenicity, and Immunogenicity of Intramuscular Subvirion Inactivated Monovalent Influenza A/H5N1 Virus Vaccine Administered at Different Dose Levels Given With and Without MF59 Adjuvant
Status: Archived
The Hope Clinic of the Emory Vaccine Center
mi
from
Decatur, GA
H5N1 Mix and Match With MF59
A Randomized, Double-Blinded, Controlled, Phase I Study in Healthy Adults to Assess the Safety, Reactogenicity, and Immunogenicity of Intramuscular Subvirion Inactivated Monovalent Influenza A/H5N1 Virus Vaccine Administered at Different Dose Levels Given With and Without MF59 Adjuvant
Status: Archived
Updated: 1/1/1970
The Hope Clinic of the Emory Vaccine Center
mi
from
Decatur, GA
H5N1 Mix and Match With MF59
A Randomized, Double-Blinded, Controlled, Phase I Study in Healthy Adults to Assess the Safety, Reactogenicity, and Immunogenicity of Intramuscular Subvirion Inactivated Monovalent Influenza A/H5N1 Virus Vaccine Administered at Different Dose Levels Given With and Without MF59 Adjuvant
Status: Archived
University of Iowa
mi
from
Iowa City, IA
H5N1 Mix and Match With MF59
A Randomized, Double-Blinded, Controlled, Phase I Study in Healthy Adults to Assess the Safety, Reactogenicity, and Immunogenicity of Intramuscular Subvirion Inactivated Monovalent Influenza A/H5N1 Virus Vaccine Administered at Different Dose Levels Given With and Without MF59 Adjuvant
Status: Archived
Updated: 1/1/1970
University of Iowa
mi
from
Iowa City, IA
H5N1 Mix and Match With MF59
A Randomized, Double-Blinded, Controlled, Phase I Study in Healthy Adults to Assess the Safety, Reactogenicity, and Immunogenicity of Intramuscular Subvirion Inactivated Monovalent Influenza A/H5N1 Virus Vaccine Administered at Different Dose Levels Given With and Without MF59 Adjuvant
Status: Archived
St Louis University
mi
from
St Louis, MO
H5N1 Mix and Match With MF59
A Randomized, Double-Blinded, Controlled, Phase I Study in Healthy Adults to Assess the Safety, Reactogenicity, and Immunogenicity of Intramuscular Subvirion Inactivated Monovalent Influenza A/H5N1 Virus Vaccine Administered at Different Dose Levels Given With and Without MF59 Adjuvant
Status: Archived
Updated: 1/1/1970
St Louis University
mi
from
St Louis, MO
H5N1 Mix and Match With MF59
A Randomized, Double-Blinded, Controlled, Phase I Study in Healthy Adults to Assess the Safety, Reactogenicity, and Immunogenicity of Intramuscular Subvirion Inactivated Monovalent Influenza A/H5N1 Virus Vaccine Administered at Different Dose Levels Given With and Without MF59 Adjuvant
Status: Archived
Cincinnati Children's Hospital Medical Center
mi
from
Cincinnati, OH
H5N1 Mix and Match With MF59
A Randomized, Double-Blinded, Controlled, Phase I Study in Healthy Adults to Assess the Safety, Reactogenicity, and Immunogenicity of Intramuscular Subvirion Inactivated Monovalent Influenza A/H5N1 Virus Vaccine Administered at Different Dose Levels Given With and Without MF59 Adjuvant
Status: Archived
Updated: 1/1/1970
Cincinnati Children's Hospital Medical Center
mi
from
Cincinnati, OH
Safety Study of Flufirvitide-3 Nasal Spray in Healthy Subjects
A Phase 1, Randomized, Double-blind, Placebo-controlled Assessment of the Safety, Tolerability and Pharmacokinetics of Escalating Single Doses of Flufirvitide-3 Nasal Spray in Healthy Subjects
Status: Archived
Quintiles, Inc.
mi
from
Overland Park, KA
Safety Study of Flufirvitide-3 Nasal Spray in Healthy Subjects
A Phase 1, Randomized, Double-blind, Placebo-controlled Assessment of the Safety, Tolerability and Pharmacokinetics of Escalating Single Doses of Flufirvitide-3 Nasal Spray in Healthy Subjects
Status: Archived
Updated: 1/1/1970
Quintiles, Inc.
mi
from
Overland Park, KA
"Quidel Reader Influenza A + B Test 510(k) and CLIA Waiver Field Study"
"Quidel Reader Influenza A + B Test 510(k) and CLIA Waiver Field Study"
Status: Archived
Los Angeles County-USC Medical Center
mi
from
Los Angeles, CA
"Quidel Reader Influenza A + B Test 510(k) and CLIA Waiver Field Study"
"Quidel Reader Influenza A + B Test 510(k) and CLIA Waiver Field Study"
Status: Archived
Updated: 1/1/1970
Los Angeles County-USC Medical Center
mi
from
Los Angeles, CA
"Quidel Reader Influenza A + B Test 510(k) and CLIA Waiver Field Study"
"Quidel Reader Influenza A + B Test 510(k) and CLIA Waiver Field Study"
Status: Archived
Santo Nino Medical Clinic
mi
from
Panorama City, CA
"Quidel Reader Influenza A + B Test 510(k) and CLIA Waiver Field Study"
"Quidel Reader Influenza A + B Test 510(k) and CLIA Waiver Field Study"
Status: Archived
Updated: 1/1/1970
Santo Nino Medical Clinic
mi
from
Panorama City, CA
"Quidel Reader Influenza A + B Test 510(k) and CLIA Waiver Field Study"
"Quidel Reader Influenza A + B Test 510(k) and CLIA Waiver Field Study"
Status: Archived
La Jolla Pediatrics
mi
from
San Diego, CA
"Quidel Reader Influenza A + B Test 510(k) and CLIA Waiver Field Study"
"Quidel Reader Influenza A + B Test 510(k) and CLIA Waiver Field Study"
Status: Archived
Updated: 1/1/1970
La Jolla Pediatrics
mi
from
San Diego, CA
"Quidel Reader Influenza A + B Test 510(k) and CLIA Waiver Field Study"
"Quidel Reader Influenza A + B Test 510(k) and CLIA Waiver Field Study"
Status: Archived
Complete Family Care
mi
from
Northglenn, CO
"Quidel Reader Influenza A + B Test 510(k) and CLIA Waiver Field Study"
"Quidel Reader Influenza A + B Test 510(k) and CLIA Waiver Field Study"
Status: Archived
Updated: 1/1/1970
Complete Family Care
mi
from
Northglenn, CO
"Quidel Reader Influenza A + B Test 510(k) and CLIA Waiver Field Study"
"Quidel Reader Influenza A + B Test 510(k) and CLIA Waiver Field Study"
Status: Archived
Adriana Castro, MD
mi
from
Miami, FL
"Quidel Reader Influenza A + B Test 510(k) and CLIA Waiver Field Study"
"Quidel Reader Influenza A + B Test 510(k) and CLIA Waiver Field Study"
Status: Archived
Updated: 1/1/1970
Adriana Castro, MD
mi
from
Miami, FL
"Quidel Reader Influenza A + B Test 510(k) and CLIA Waiver Field Study"
"Quidel Reader Influenza A + B Test 510(k) and CLIA Waiver Field Study"
Status: Archived
Teena Hughes, MD
mi
from
Tampa, FL
"Quidel Reader Influenza A + B Test 510(k) and CLIA Waiver Field Study"
"Quidel Reader Influenza A + B Test 510(k) and CLIA Waiver Field Study"
Status: Archived
Updated: 1/1/1970
Teena Hughes, MD
mi
from
Tampa, FL
"Quidel Reader Influenza A + B Test 510(k) and CLIA Waiver Field Study"
"Quidel Reader Influenza A + B Test 510(k) and CLIA Waiver Field Study"
Status: Archived
DuPage Family Medicine
mi
from
Naperville, IL
"Quidel Reader Influenza A + B Test 510(k) and CLIA Waiver Field Study"
"Quidel Reader Influenza A + B Test 510(k) and CLIA Waiver Field Study"
Status: Archived
Updated: 1/1/1970
DuPage Family Medicine
mi
from
Naperville, IL
"Quidel Reader Influenza A + B Test 510(k) and CLIA Waiver Field Study"
"Quidel Reader Influenza A + B Test 510(k) and CLIA Waiver Field Study"
Status: Archived
Paul Janson, MD
mi
from
Florence, KY
"Quidel Reader Influenza A + B Test 510(k) and CLIA Waiver Field Study"
"Quidel Reader Influenza A + B Test 510(k) and CLIA Waiver Field Study"
Status: Archived
Updated: 1/1/1970
Paul Janson, MD
mi
from
Florence, KY
"Quidel Reader Influenza A + B Test 510(k) and CLIA Waiver Field Study"
"Quidel Reader Influenza A + B Test 510(k) and CLIA Waiver Field Study"
Status: Archived
Paul McLaughlin, MD
mi
from
Mt. Sterling, KY
"Quidel Reader Influenza A + B Test 510(k) and CLIA Waiver Field Study"
"Quidel Reader Influenza A + B Test 510(k) and CLIA Waiver Field Study"
Status: Archived
Updated: 1/1/1970
Paul McLaughlin, MD
mi
from
Mt. Sterling, KY
"Quidel Reader Influenza A + B Test 510(k) and CLIA Waiver Field Study"
"Quidel Reader Influenza A + B Test 510(k) and CLIA Waiver Field Study"
Status: Archived
Kamakshi Neelkantan, MD
mi
from
Edgewood, MD
"Quidel Reader Influenza A + B Test 510(k) and CLIA Waiver Field Study"
"Quidel Reader Influenza A + B Test 510(k) and CLIA Waiver Field Study"
Status: Archived
Updated: 1/1/1970
Kamakshi Neelkantan, MD
mi
from
Edgewood, MD
"Quidel Reader Influenza A + B Test 510(k) and CLIA Waiver Field Study"
"Quidel Reader Influenza A + B Test 510(k) and CLIA Waiver Field Study"
Status: Archived
Priority Care Pediatrics
mi
from
Kansas City, MO
"Quidel Reader Influenza A + B Test 510(k) and CLIA Waiver Field Study"
"Quidel Reader Influenza A + B Test 510(k) and CLIA Waiver Field Study"
Status: Archived
Updated: 1/1/1970
Priority Care Pediatrics
mi
from
Kansas City, MO
"Quidel Reader Influenza A + B Test 510(k) and CLIA Waiver Field Study"
"Quidel Reader Influenza A + B Test 510(k) and CLIA Waiver Field Study"
Status: Archived
Robert Farron, DO
mi
from
Far Rockaway, NY
"Quidel Reader Influenza A + B Test 510(k) and CLIA Waiver Field Study"
"Quidel Reader Influenza A + B Test 510(k) and CLIA Waiver Field Study"
Status: Archived
Updated: 1/1/1970
Robert Farron, DO
mi
from
Far Rockaway, NY
"Quidel Reader Influenza A + B Test 510(k) and CLIA Waiver Field Study"
"Quidel Reader Influenza A + B Test 510(k) and CLIA Waiver Field Study"
Status: Archived
Twelve Corners Pediatrics
mi
from
Rochester, NY
"Quidel Reader Influenza A + B Test 510(k) and CLIA Waiver Field Study"
"Quidel Reader Influenza A + B Test 510(k) and CLIA Waiver Field Study"
Status: Archived
Updated: 1/1/1970
Twelve Corners Pediatrics
mi
from
Rochester, NY
"Quidel Reader Influenza A + B Test 510(k) and CLIA Waiver Field Study"
"Quidel Reader Influenza A + B Test 510(k) and CLIA Waiver Field Study"
Status: Archived
Montrose Family Practice
mi
from
Akron, OH
"Quidel Reader Influenza A + B Test 510(k) and CLIA Waiver Field Study"
"Quidel Reader Influenza A + B Test 510(k) and CLIA Waiver Field Study"
Status: Archived
Updated: 1/1/1970
Montrose Family Practice
mi
from
Akron, OH
"Quidel Reader Influenza A + B Test 510(k) and CLIA Waiver Field Study"
"Quidel Reader Influenza A + B Test 510(k) and CLIA Waiver Field Study"
Status: Archived
Norristown Family Physicians
mi
from
Norristown, PA
"Quidel Reader Influenza A + B Test 510(k) and CLIA Waiver Field Study"
"Quidel Reader Influenza A + B Test 510(k) and CLIA Waiver Field Study"
Status: Archived
Updated: 1/1/1970
Norristown Family Physicians
mi
from
Norristown, PA
"Quidel Reader Influenza A + B Test 510(k) and CLIA Waiver Field Study"
"Quidel Reader Influenza A + B Test 510(k) and CLIA Waiver Field Study"
Status: Archived
Dell's Children's Medical Center
mi
from
Austin, TX
"Quidel Reader Influenza A + B Test 510(k) and CLIA Waiver Field Study"
"Quidel Reader Influenza A + B Test 510(k) and CLIA Waiver Field Study"
Status: Archived
Updated: 1/1/1970
Dell's Children's Medical Center
mi
from
Austin, TX
Safety of Synbiotics as Adjuvant to Influenza Vaccine in Elderly
A Phase I Trial of the Safety and Efficacy of Adjuvant AKSB (Agri-King Synbiotic) Synbiotic in Patients 65 Years of Age and Older Receiving the Influenza Vaccine
Status: Archived
Mayo Clinic Rochester
mi
from
Rochester, MN
Safety of Synbiotics as Adjuvant to Influenza Vaccine in Elderly
A Phase I Trial of the Safety and Efficacy of Adjuvant AKSB (Agri-King Synbiotic) Synbiotic in Patients 65 Years of Age and Older Receiving the Influenza Vaccine
Status: Archived
Updated: 1/1/1970
Mayo Clinic Rochester
mi
from
Rochester, MN
Safety, Tolerability and Immunogenicity of a Plant-Made H1 VLP Influenza Vaccine in Adults
Safety, Tolerability and Immunogenicity of a Plant-Made H1 VLP Influenza Vaccine in Adults
Status: Archived
Accelovance
mi
from
Rockville, MD
Safety, Tolerability and Immunogenicity of a Plant-Made H1 VLP Influenza Vaccine in Adults
Safety, Tolerability and Immunogenicity of a Plant-Made H1 VLP Influenza Vaccine in Adults
Status: Archived
Updated: 1/1/1970
Accelovance
mi
from
Rockville, MD
Collection and Testing of Respiratory Samples
Testing of Respiratory Specimens for the Validation of the QIAGEN ResPlex II Advanced Panel Test and the Artus Influenza A/B RT-PCR Test
Status: Archived
University of Arizona
mi
from
Tucson, AZ
Collection and Testing of Respiratory Samples
Testing of Respiratory Specimens for the Validation of the QIAGEN ResPlex II Advanced Panel Test and the Artus Influenza A/B RT-PCR Test
Status: Archived
Updated: 1/1/1970
University of Arizona
mi
from
Tucson, AZ
Collection and Testing of Respiratory Samples
Testing of Respiratory Specimens for the Validation of the QIAGEN ResPlex II Advanced Panel Test and the Artus Influenza A/B RT-PCR Test
Status: Archived
Albany Medical Center Hospital
mi
from
Albany, NY
Collection and Testing of Respiratory Samples
Testing of Respiratory Specimens for the Validation of the QIAGEN ResPlex II Advanced Panel Test and the Artus Influenza A/B RT-PCR Test
Status: Archived
Updated: 1/1/1970
Albany Medical Center Hospital
mi
from
Albany, NY
Collection and Testing of Respiratory Samples
Testing of Respiratory Specimens for the Validation of the QIAGEN ResPlex II Advanced Panel Test and the Artus Influenza A/B RT-PCR Test
Status: Archived
Wadsworth Center, New York State Department of Health
mi
from
Albany, NY
Collection and Testing of Respiratory Samples
Testing of Respiratory Specimens for the Validation of the QIAGEN ResPlex II Advanced Panel Test and the Artus Influenza A/B RT-PCR Test
Status: Archived
Updated: 1/1/1970
Wadsworth Center, New York State Department of Health
mi
from
Albany, NY
Collection and Testing of Respiratory Samples
Testing of Respiratory Specimens for the Validation of the QIAGEN ResPlex II Advanced Panel Test and the Artus Influenza A/B RT-PCR Test
Status: Archived
University of North Carolina Hospital at Chapel Hill
mi
from
Chapel Hill, NC
Collection and Testing of Respiratory Samples
Testing of Respiratory Specimens for the Validation of the QIAGEN ResPlex II Advanced Panel Test and the Artus Influenza A/B RT-PCR Test
Status: Archived
Updated: 1/1/1970
University of North Carolina Hospital at Chapel Hill
mi
from
Chapel Hill, NC
Collection and Testing of Respiratory Samples
Testing of Respiratory Specimens for the Validation of the QIAGEN ResPlex II Advanced Panel Test and the Artus Influenza A/B RT-PCR Test
Status: Archived
Ohio State University
mi
from
Columbus, OH
Collection and Testing of Respiratory Samples
Testing of Respiratory Specimens for the Validation of the QIAGEN ResPlex II Advanced Panel Test and the Artus Influenza A/B RT-PCR Test
Status: Archived
Updated: 1/1/1970
Ohio State University
mi
from
Columbus, OH
Nontypeable H. Influenzae in Healthy Adults
Phase I/II Single-Site, Randomized and Double-Blinded Trial to Further Characterize the HCD50, HCD90 and Transmissibility of Nontypeable Haemophilus Influenzae in a Human Colonization Model in Healthy Adults
Status: Archived
University of Iowa
mi
from
Iowa City, IA
Nontypeable H. Influenzae in Healthy Adults
Phase I/II Single-Site, Randomized and Double-Blinded Trial to Further Characterize the HCD50, HCD90 and Transmissibility of Nontypeable Haemophilus Influenzae in a Human Colonization Model in Healthy Adults
Status: Archived
Updated: 1/1/1970
University of Iowa
mi
from
Iowa City, IA
Reactogenicity, Immunogenicity of Trivalent Influenza Vaccine With Recombinant Interferon Alpha Among Chronic Lymphocytic Leukemia
A Randomized, Phase I/II Clinical Trial Evaluating the Safety, Reactogenicity, and Immunogenicity of Licensed Trivalent Influenza Vaccine Administered With Recombinant Interferon Alpha Among Patients With Chronic Lymphocytic Leukemia
Status: Archived
University of Texas M.D. Anderson Cancer Center
mi
from
Houston, TX
Reactogenicity, Immunogenicity of Trivalent Influenza Vaccine With Recombinant Interferon Alpha Among Chronic Lymphocytic Leukemia
A Randomized, Phase I/II Clinical Trial Evaluating the Safety, Reactogenicity, and Immunogenicity of Licensed Trivalent Influenza Vaccine Administered With Recombinant Interferon Alpha Among Patients With Chronic Lymphocytic Leukemia
Status: Archived
Updated: 1/1/1970
University of Texas M.D. Anderson Cancer Center
mi
from
Houston, TX
Safety and Immunogenicity of VAX125 Influenza Vaccine in Community-living Adults >= 65 Years of Age
A Phase II, Open-label, Escalating Dose-ranging Study to Evaluate the Safety and Immunogenicity of VAX125 Influenza Vaccine in Community-living Adults ≥65 Years of Age
Status: Archived
Johnson County Clin-Trials
mi
from
Lenexa, KA
Safety and Immunogenicity of VAX125 Influenza Vaccine in Community-living Adults >= 65 Years of Age
A Phase II, Open-label, Escalating Dose-ranging Study to Evaluate the Safety and Immunogenicity of VAX125 Influenza Vaccine in Community-living Adults ≥65 Years of Age
Status: Archived
Updated: 1/1/1970
Johnson County Clin-Trials
mi
from
Lenexa, KA
Safety and Immunogenicity of VAX125 Influenza Vaccine in Community-living Adults >= 65 Years of Age
A Phase II, Open-label, Escalating Dose-ranging Study to Evaluate the Safety and Immunogenicity of VAX125 Influenza Vaccine in Community-living Adults ≥65 Years of Age
Status: Archived
Strong Memorial Hospital (University of Rochester School of Medicine)
mi
from
Rochester, NY
Safety and Immunogenicity of VAX125 Influenza Vaccine in Community-living Adults >= 65 Years of Age
A Phase II, Open-label, Escalating Dose-ranging Study to Evaluate the Safety and Immunogenicity of VAX125 Influenza Vaccine in Community-living Adults ≥65 Years of Age
Status: Archived
Updated: 1/1/1970
Strong Memorial Hospital (University of Rochester School of Medicine)
mi
from
Rochester, NY
Safety and Immunogenicity of VAX125 Influenza Vaccine in Community-living Adults >= 65 Years of Age
A Phase II, Open-label, Escalating Dose-ranging Study to Evaluate the Safety and Immunogenicity of VAX125 Influenza Vaccine in Community-living Adults ≥65 Years of Age
Status: Archived
Coastal Carolina Research Center
mi
from
Mt Pleasant, SC
Safety and Immunogenicity of VAX125 Influenza Vaccine in Community-living Adults >= 65 Years of Age
A Phase II, Open-label, Escalating Dose-ranging Study to Evaluate the Safety and Immunogenicity of VAX125 Influenza Vaccine in Community-living Adults ≥65 Years of Age
Status: Archived
Updated: 1/1/1970
Coastal Carolina Research Center
mi
from
Mt Pleasant, SC
STIP: Statin Trial for Influenza Patients
Randomized, Placebo Controlled Trial of the Effectiveness of Statins for Preventing Mortality Following ICU Admission for Influenza Complications
Status: Archived
University of Arkansas
mi
from
Little Rock, AR
STIP: Statin Trial for Influenza Patients
Randomized, Placebo Controlled Trial of the Effectiveness of Statins for Preventing Mortality Following ICU Admission for Influenza Complications
Status: Archived
Updated: 1/1/1970
University of Arkansas
mi
from
Little Rock, AR
STIP: Statin Trial for Influenza Patients
Randomized, Placebo Controlled Trial of the Effectiveness of Statins for Preventing Mortality Following ICU Admission for Influenza Complications
Status: Archived
Maricopa Integrated Health System
mi
from
Phoenix, AZ
STIP: Statin Trial for Influenza Patients
Randomized, Placebo Controlled Trial of the Effectiveness of Statins for Preventing Mortality Following ICU Admission for Influenza Complications
Status: Archived
Updated: 1/1/1970
Maricopa Integrated Health System
mi
from
Phoenix, AZ
STIP: Statin Trial for Influenza Patients
Randomized, Placebo Controlled Trial of the Effectiveness of Statins for Preventing Mortality Following ICU Admission for Influenza Complications
Status: Archived
Stanford university Hospital and Clinics
mi
from
Stanford, CA
STIP: Statin Trial for Influenza Patients
Randomized, Placebo Controlled Trial of the Effectiveness of Statins for Preventing Mortality Following ICU Admission for Influenza Complications
Status: Archived
Updated: 1/1/1970
Stanford university Hospital and Clinics
mi
from
Stanford, CA
STIP: Statin Trial for Influenza Patients
Randomized, Placebo Controlled Trial of the Effectiveness of Statins for Preventing Mortality Following ICU Admission for Influenza Complications
Status: Archived
Northwestern University
mi
from
Chicago, IL
STIP: Statin Trial for Influenza Patients
Randomized, Placebo Controlled Trial of the Effectiveness of Statins for Preventing Mortality Following ICU Admission for Influenza Complications
Status: Archived
Updated: 1/1/1970
Northwestern University
mi
from
Chicago, IL
STIP: Statin Trial for Influenza Patients
Randomized, Placebo Controlled Trial of the Effectiveness of Statins for Preventing Mortality Following ICU Admission for Influenza Complications
Status: Archived
University of Iowa
mi
from
Iowa City, IA
STIP: Statin Trial for Influenza Patients
Randomized, Placebo Controlled Trial of the Effectiveness of Statins for Preventing Mortality Following ICU Admission for Influenza Complications
Status: Archived
Updated: 1/1/1970
University of Iowa
mi
from
Iowa City, IA
STIP: Statin Trial for Influenza Patients
Randomized, Placebo Controlled Trial of the Effectiveness of Statins for Preventing Mortality Following ICU Admission for Influenza Complications
Status: Archived
Johns Hopkins Hosp
mi
from
Baltimore, MD
STIP: Statin Trial for Influenza Patients
Randomized, Placebo Controlled Trial of the Effectiveness of Statins for Preventing Mortality Following ICU Admission for Influenza Complications
Status: Archived
Updated: 1/1/1970
Johns Hopkins Hosp
mi
from
Baltimore, MD
STIP: Statin Trial for Influenza Patients
Randomized, Placebo Controlled Trial of the Effectiveness of Statins for Preventing Mortality Following ICU Admission for Influenza Complications
Status: Archived
Boston Med Center
mi
from
Boston, MA
STIP: Statin Trial for Influenza Patients
Randomized, Placebo Controlled Trial of the Effectiveness of Statins for Preventing Mortality Following ICU Admission for Influenza Complications
Status: Archived
Updated: 1/1/1970
Boston Med Center
mi
from
Boston, MA
STIP: Statin Trial for Influenza Patients
Randomized, Placebo Controlled Trial of the Effectiveness of Statins for Preventing Mortality Following ICU Admission for Influenza Complications
Status: Archived
Baystate Med Ctr of Springfield
mi
from
Springfield, MA
STIP: Statin Trial for Influenza Patients
Randomized, Placebo Controlled Trial of the Effectiveness of Statins for Preventing Mortality Following ICU Admission for Influenza Complications
Status: Archived
Updated: 1/1/1970
Baystate Med Ctr of Springfield
mi
from
Springfield, MA